IDH1 and central nervous system cancer: The 2021 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS) has refined the molecular definition of ODGs, emphasizing the importance of isocitrate dehydrogenase (IDH)-mutant status accompanied by 1p/19q co-deletion [4].